Salta alla navigazione principale Salta alla ricerca Salta al contenuto principale

Sutureless Bioprostheses for Aortic Valve Replacement: An Updated Systematic Review with Long-Term Results

  • Giovanni Alfonso Chiariello*
  • , Michele Di Mauro
  • , Emmanuel Villa
  • , Marinos Koulouroudias
  • , Piergiorgio Bruno
  • , Andrea Mazza
  • , Annalisa Pasquini
  • , Serena D'Avino
  • , Gaia De Angelis
  • , Kiara Corigliano
  • , Alberta Marcolini
  • , Edoardo Zancanaro
  • , Guglielmo Saitto
  • , Paolo Meani
  • , Massimo Massetti
  • , Roberto Lorusso
  • *Autore corrispondente per questo lavoro
  • Maastricht University
  • Poliambulanza Foundation
  • Nottingham University Hospitals NHS Trust
  • San Raffaele Scientific Institute
  • San Camillo Hospital

Risultato della ricerca: Contributo in rivistaArticolo

Abstract

Background: In recent years, in case of aortic valve replacement (AVR), a significant increase in the use of bioprostheses has been observed. The Perceval sutureless bioprosthesis has proven to be safe and reliable in the short and mid-term, with limited but promising long-term results. An updated systematic review with the long-term results of patients who underwent a sutureless bioprosthesis implantation with a Perceval biological valve is herewith presented. Methods: Studies published between 2015 and 2024, including the long-term outcomes—with clinical as well as echocardiographic information for up to five years—of patients who underwent a Perceval implantation for AVR were selected from the published literature. The Cochrane GRADE system was used to assess the study quality, and the risk of bias in non-randomized studies (ROBINS-I) tool was used to evaluate studies. Results: Ten studies were selected with an overall number of 5221 patients. The long-term survival ranged from 64.8 to 87.9%, freedom from structural valve degeneration (SVD) from 96.1 to 100%, freedom from significant paravalvular leak from 98.5 to 100%, freedom from prosthetic endocarditis from 90.7 to 99%, and freedom from reintervention from 94 to 100%. The long-term mortality ranged from 6.5 to 27.4%. SVD was observed in 0–4.8% patients. Significant paravalvular leak was observed in 0–3.4% patients, and infective endocarditis was observed in 0–3.4%. A bioprosthesis-related reintervention at long-term follow-up was required for 0–4.3% of patients, and 1.7–7.1% of patients required a late new pacemaker implantation. The transprosthetic mean pressure gradient ranged from 9 to 14.7 mmHg, peak pressure gradient ranged from 17.8 to 26.5 mmHg, and EOA ranged from 1.5 to 1.7 cm2. Conclusions: This systematic review shows that there is still a paucity of data about sutureless bioprostheses. Nevertheless, the clinical results from prospective studies or retrospective series are encouraging. Medium- and long-term results seem to support the increasing use of this type of prosthesis.
Lingua originaleInglese
pagine (da-a)N/A-N/A
RivistaJournal of Clinical Medicine
Volume13
Numero di pubblicazione22
DOI
Stato di pubblicazionePubblicato - 2024

All Science Journal Classification (ASJC) codes

  • Medicina Generale

Keywords

  • aortic valve
  • bioprosthetic valve
  • long-term outcomes
  • sutureless

Fingerprint

Entra nei temi di ricerca di 'Sutureless Bioprostheses for Aortic Valve Replacement: An Updated Systematic Review with Long-Term Results'. Insieme formano una fingerprint unica.

Cita questo